| Evaluating comorbidities and life expectancy in patients undergoing LDCT screening in the real world setting |
Jonathan Iaccarino |
Boston University Medical Campus |
NLST |
May 19, 2017 |
NLST-309 |
| Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. |
Lauren King |
NCI-DCEG |
PLCO |
Jan 30, 2020 |
PLCO-576 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
NLST |
Apr 13, 2019 |
NLST-498 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Oct 27, 2020 |
PLCO-683 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the NLST data |
Dongfeng Wu |
University of Louisville |
NLST |
May 16, 2014 |
NLST-73 |
| Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data |
Dongfeng Wu |
University of Louisville |
PLCO |
May 21, 2014 |
PLCO-86 |
| Evaluating lung cancer risks with time-to-event data: state-of-the-art model with certified performance |
Mingzhe Wu |
Fudan University |
NLST |
Jan 31, 2018 |
NLST-387 |
| Evaluating Predictors of Improved Outcomes Among Patients Undergoing Surgery for Lung Cancer |
Chi-Fu Jeffrey Yang |
Massachusetts General Hospital |
NLST |
Jun 21, 2022 |
NLST-922 |
| Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial |
Timothy Church |
University of Minnesota |
PLCO |
Mar 31, 2006 |
2006-0307 |
| Evaluating six-step parsimonious quadratic logistic regression for risk prediction |
Stuart Baker |
National Cancer Institute |
NLST |
Jun 12, 2020 |
NLST-676 |
| Evaluating six-step parsimonious quadratic logistic regression for risk prediction |
Stuart Baker |
National Cancer Institute |
PLCO |
Jun 18, 2020 |
PLCO-637 |
| Evaluating the Cost-Effectiveness of the Sybil Model for Lung Nodule Surveillance in Cancer Screening |
Kei Chuen Ma |
Massachusetts Institute of Technology |
NLST |
Apr 18, 2024 |
NLST-1235 |
| Evaluating the Impact of Preoperative Characteristics on Outcomes of Patients Undergoing Curative-intent Treatment in the NLST |
Chi-Fu Yang |
Stanford |
NLST |
Nov 25, 2019 |
NLST-607 |
| Evaluating the Potential for Biomarker Use in CT Screening |
Hilary Robbins |
International Agency for Research on Cancer (IARC) |
NLST |
Jan 31, 2019 |
NLST-476 |
| Evaluating the Potential for Biomarker Use in CT Screening |
Hilary Robbins |
International Agency for Research on Cancer (IARC) |
PLCO |
Feb 20, 2019 |
PLCO-456 |
| Evaluation and Optimization of Lung Cancer Screening Effectiveness Using the NLST Dataset |
Ted Li |
China Changzhou Lunghealth Medical Equipment Co., Ltd. |
NLST |
Sep 18, 2023 |
NLST-1123 |
| Evaluation of a deep-learning algorithm to assist in the detection of features suggestive of lung cancer on chest x-rays |
Gaetan Dissez |
behold.ai |
PLCO |
Jul 6, 2021 |
PLCOI-794 |
| Evaluation of a deep-learning algorithm to assist in the detection of features suggestive of lung cancer on chest x-rays. |
Gaetan Dissez |
behold.ai |
NLST |
Jun 14, 2021 |
NLST-799 |
